Teva to get U.S. rights to Andrx products

12/12/2003 | Ha'aretz (Tel Aviv, Israel)

Israel's Teva Pharmaceuticals will get exclusive marketing rights in the U.S. and Canada to Andrx's line of generic oral contraceptive products now awaiting regulatory approval. Financial terms were not disclosed, but analysts said the deal fills holes in Teva's product line and Andrx gets Teva's marketing channels.

View Full Article in:

Ha'aretz (Tel Aviv, Israel)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Associate Director, Compliance Business Partner I
Boehringer Ingelheim
Ridgefield, CT
European Sales Manager
SentreHEART, Inc.
Germany, Benelux, UK
REG AFFAIRS PROJ MGR - 1400000A7F
Abbott
San Jose, CA
SPECIALIST II SYSTEMS INTEGRATION - 140000033P
Abbott
Dallas, TX
Attorney
U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Administration Office of the Chief Counsel
Silver Spring, MD, MD